Cargando…
PLD3 epigenetic changes in the hippocampus of Alzheimer’s disease
BACKGROUND: Whole-exome sequencing has revealed a rare missense variant in PLD3 gene (rs145999145) to be associated with late onset Alzheimer’s disease (AD). Nevertheless, the association remains controversial and little is known about the role of PLD3 in AD. Interestingly, PLD3 encodes a phospholip...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134774/ https://www.ncbi.nlm.nih.gov/pubmed/30208929 http://dx.doi.org/10.1186/s13148-018-0547-3 |
_version_ | 1783354726212960256 |
---|---|
author | Blanco-Luquin, Idoia Altuna, Miren Sánchez-Ruiz de Gordoa, Javier Urdánoz-Casado, Amaya Roldán, Miren Cámara, María Zelaya, Victoria Erro, María Elena Echavarri, Carmen Mendioroz, Maite |
author_facet | Blanco-Luquin, Idoia Altuna, Miren Sánchez-Ruiz de Gordoa, Javier Urdánoz-Casado, Amaya Roldán, Miren Cámara, María Zelaya, Victoria Erro, María Elena Echavarri, Carmen Mendioroz, Maite |
author_sort | Blanco-Luquin, Idoia |
collection | PubMed |
description | BACKGROUND: Whole-exome sequencing has revealed a rare missense variant in PLD3 gene (rs145999145) to be associated with late onset Alzheimer’s disease (AD). Nevertheless, the association remains controversial and little is known about the role of PLD3 in AD. Interestingly, PLD3 encodes a phospholipase that may be involved in amyloid precursor protein (APP) processing. Our aim was to gain insight into the epigenetic mechanisms regulating PLD3 gene expression in the human hippocampus affected by AD. RESULTS: We assessed PLD3 mRNA expression by qPCR and protein levels by Western blot in frozen hippocampal samples from a cohort of neuropathologically confirmed pure AD cases and controls. Next, we profiled DNA methylation at cytosine-phosphate-guanine dinucleotide (CpG) site resolution by pyrosequencing and further validated results by bisulfite cloning sequencing in two promoter regions of the PLD3 gene. A 1.67-fold decrease in PLD3 mRNA levels (p value < 0.001) was observed in the hippocampus of AD cases compared to controls, and a slight decrease was also found by Western blot at protein level. Moreover, PLD3 mRNA levels inversely correlated with the average area of β-amyloid burden (tau-b = − 0,331; p value < 0.01) in the hippocampus. A differentially methylated region was identified within the alternative promoter of PLD3 gene showing higher DNA methylation levels in the AD hippocampus compared to controls (21.7 ± 4.7% vs. 18.3 ± 4.8%; p value < 0.05). CONCLUSIONS: PLD3 gene is downregulated in the human hippocampus in AD cases compared to controls. Altered epigenetic mechanisms, such as differential DNA methylation within an alternative promoter of PLD3 gene, may be involved in the pathological processes of AD. Moreover, PLD3 mRNA expression inversely correlates with hippocampal β-amyloid burden, which adds evidence to the hypothesis that PLD3 protein may contribute to AD development by modifying APP processing. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13148-018-0547-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6134774 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-61347742018-09-15 PLD3 epigenetic changes in the hippocampus of Alzheimer’s disease Blanco-Luquin, Idoia Altuna, Miren Sánchez-Ruiz de Gordoa, Javier Urdánoz-Casado, Amaya Roldán, Miren Cámara, María Zelaya, Victoria Erro, María Elena Echavarri, Carmen Mendioroz, Maite Clin Epigenetics Research BACKGROUND: Whole-exome sequencing has revealed a rare missense variant in PLD3 gene (rs145999145) to be associated with late onset Alzheimer’s disease (AD). Nevertheless, the association remains controversial and little is known about the role of PLD3 in AD. Interestingly, PLD3 encodes a phospholipase that may be involved in amyloid precursor protein (APP) processing. Our aim was to gain insight into the epigenetic mechanisms regulating PLD3 gene expression in the human hippocampus affected by AD. RESULTS: We assessed PLD3 mRNA expression by qPCR and protein levels by Western blot in frozen hippocampal samples from a cohort of neuropathologically confirmed pure AD cases and controls. Next, we profiled DNA methylation at cytosine-phosphate-guanine dinucleotide (CpG) site resolution by pyrosequencing and further validated results by bisulfite cloning sequencing in two promoter regions of the PLD3 gene. A 1.67-fold decrease in PLD3 mRNA levels (p value < 0.001) was observed in the hippocampus of AD cases compared to controls, and a slight decrease was also found by Western blot at protein level. Moreover, PLD3 mRNA levels inversely correlated with the average area of β-amyloid burden (tau-b = − 0,331; p value < 0.01) in the hippocampus. A differentially methylated region was identified within the alternative promoter of PLD3 gene showing higher DNA methylation levels in the AD hippocampus compared to controls (21.7 ± 4.7% vs. 18.3 ± 4.8%; p value < 0.05). CONCLUSIONS: PLD3 gene is downregulated in the human hippocampus in AD cases compared to controls. Altered epigenetic mechanisms, such as differential DNA methylation within an alternative promoter of PLD3 gene, may be involved in the pathological processes of AD. Moreover, PLD3 mRNA expression inversely correlates with hippocampal β-amyloid burden, which adds evidence to the hypothesis that PLD3 protein may contribute to AD development by modifying APP processing. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13148-018-0547-3) contains supplementary material, which is available to authorized users. BioMed Central 2018-09-12 /pmc/articles/PMC6134774/ /pubmed/30208929 http://dx.doi.org/10.1186/s13148-018-0547-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Blanco-Luquin, Idoia Altuna, Miren Sánchez-Ruiz de Gordoa, Javier Urdánoz-Casado, Amaya Roldán, Miren Cámara, María Zelaya, Victoria Erro, María Elena Echavarri, Carmen Mendioroz, Maite PLD3 epigenetic changes in the hippocampus of Alzheimer’s disease |
title | PLD3 epigenetic changes in the hippocampus of Alzheimer’s disease |
title_full | PLD3 epigenetic changes in the hippocampus of Alzheimer’s disease |
title_fullStr | PLD3 epigenetic changes in the hippocampus of Alzheimer’s disease |
title_full_unstemmed | PLD3 epigenetic changes in the hippocampus of Alzheimer’s disease |
title_short | PLD3 epigenetic changes in the hippocampus of Alzheimer’s disease |
title_sort | pld3 epigenetic changes in the hippocampus of alzheimer’s disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134774/ https://www.ncbi.nlm.nih.gov/pubmed/30208929 http://dx.doi.org/10.1186/s13148-018-0547-3 |
work_keys_str_mv | AT blancoluquinidoia pld3epigeneticchangesinthehippocampusofalzheimersdisease AT altunamiren pld3epigeneticchangesinthehippocampusofalzheimersdisease AT sanchezruizdegordoajavier pld3epigeneticchangesinthehippocampusofalzheimersdisease AT urdanozcasadoamaya pld3epigeneticchangesinthehippocampusofalzheimersdisease AT roldanmiren pld3epigeneticchangesinthehippocampusofalzheimersdisease AT camaramaria pld3epigeneticchangesinthehippocampusofalzheimersdisease AT zelayavictoria pld3epigeneticchangesinthehippocampusofalzheimersdisease AT erromariaelena pld3epigeneticchangesinthehippocampusofalzheimersdisease AT echavarricarmen pld3epigeneticchangesinthehippocampusofalzheimersdisease AT mendiorozmaite pld3epigeneticchangesinthehippocampusofalzheimersdisease |